SIMBRINZA - 0065-4147-27 - (brinzolamide/brimonidine tartrate)

Alphabetical Index


Drug Information of SIMBRINZA

Product NDC: 0065-4147
Proprietary Name: SIMBRINZA
Non Proprietary Name: brinzolamide/brimonidine tartrate
Active Ingredient(s): 2; 10    mg/mL; mg/mL & nbsp;   brinzolamide/brimonidine tartrate
Administration Route(s): OPHTHALMIC
Dosage Form(s): SUSPENSION/ DROPS
Coding System: National Drug Codes(NDC)

Labeler Information of SIMBRINZA

Product NDC: 0065-4147
Labeler Name: Alcon Laboratories, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA204251
Marketing Category: NDA
Start Marketing Date: 20130501

Package Information of SIMBRINZA

Package NDC: 0065-4147-27
Package Description: 8 mL in 1 BOTTLE, DROPPER (0065-4147-27)

NDC Information of SIMBRINZA

NDC Code 0065-4147-27
Proprietary Name SIMBRINZA
Package Description 8 mL in 1 BOTTLE, DROPPER (0065-4147-27)
Product NDC 0065-4147
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name brinzolamide/brimonidine tartrate
Dosage Form Name SUSPENSION/ DROPS
Route Name OPHTHALMIC
Start Marketing Date 20130501
Marketing Category Name NDA
Labeler Name Alcon Laboratories, Inc.
Substance Name BRIMONIDINE TARTRATE; BRINZOLAMIDE
Strength Number 2; 10
Strength Unit mg/mL; mg/mL
Pharmaceutical Classes Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA],Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC]

Complete Information of SIMBRINZA


General Information